Conservative Treatment of Rectosigmoid Endometriosis Monitored by Transvaginal Ultrasound
Status
Conditions
Study type
Funder types
Identifiers
Details and patient eligibility
About
Background: Endometriosis is a disease affecting 8-15 % of fertile women and is a cause of abdominal pain and suffering during women's menstrual periods. A subgroup of patients with DIE has an infiltration into the rectosigmoid bowel wall (4-37%). Knowledge of the growth pattern of rectosigmoid lesions related to subjective symptoms is mandatory in order to assess the need for follow-up with transvaginal ultrasound during medical treatment.
Hypotheses:
Symptoms will follow growth of rectosigmoid endometriosis.
Material and methods:
Two different cohorts of women, based on time of diagnosis of rectosigmoid endometriosis and treatment with hormonal intrauterine device or continuous oral contraceptives will receive a questionnaire and a transvaginal ultrasound scan (measuring size and volume) at inclusion, (6) and 12 months later.
Perspectives:
Patients treated conservatively may be followed by questionnaires, thereby reducing the need for time consuming clinical controls.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
- Medically treated bowel endometriosis
Exclusion criteria
- Age below 18 years
- Bowel resection of any kind
- Cancer
Trial contacts and locations
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal